Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

swedish orphan biovitrum pty ltd - anakinra, quantity: 100 mg - injection, solution - excipient ingredients: polysorbate 80; sodium citrate dihydrate; water for injections; disodium edetate; sodium chloride - kineret (anakinra) is indicated: -for the treatment of active adult rheumatoid arthritis (ra) in patients who have had inadequate response to one or more other disease modifying anti rheumatic drugs (dmards). kineret should be given in combination with methotrexate. - in adult and paediatric patients aged 8 months and older with a body weight of 10 kg or above for the treatment of cryopyrin-associated periodic syndromes (caps) including neonatal-onset multisystem inflammatory disease (nomid) / chronic infantile neurological, cutaneous, articular syndrome (cinca), muckle-wells syndrome (mws), and familial cold autoinflammatory syndrome (fcas). - for the treatment of active systemic juvenile idiopathic arthritis (sjia) in patients 2 years and above who have failed to respond adequately to non-biological dmards

Իսրայել - անգլերեն - Ministry of Health

novartis israel ltd - canakinumab - solution for injection - canakinumab 150 mg / 1 ml - canakinumab - ►periodic fever syndromesilaris is indicated for the treatment of the following autoinflammatory periodic fever syndromes in adults, adolescents and children aged 2 years and older:cryopyrin-associated periodic syndromes (caps)ilaris is indicated for the treatment of cryopyrin-associated periodic syndromes (caps) in adults, adolescents and children aged 2 years and older with body weight of 7.5 kg or above, including:• muckle-wells syndrome (mws),• neonatal-onset multisystem inflammatory disease (nomid) / chronic infantile neurological, cutaneous, articular syndrome (cinca),• severe forms of familial cold autoinflammatory syndrome (fcas) / familial cold urticaria (fcu) presenting with signs and symptoms beyond cold-induced urticarial skin rash.►tumour necrosis factor receptor associated periodic syndrome (traps)ilaris is indicated for the treatment of tumour necrosis factor (tnf) receptor associated periodic syndrome (traps).►hyperimmunoglobulin d syndrome (hids)/ mevalonate kinase deficiency (mkd)ilaris is indicated for the treatment of hyperimmunoglobulin d syndrome (hids)/ mevalonate kinase deficiency (mkd).►familial mediterranean fever (fmf)ilaris is indicated for the treatment of familial mediterranean fever (fmf) in patients in whom colchicine is contraindicated, is not tolerated, or does not provide an adequate response despite the highest tolerable dose of colchicine.ilaris can be given as monotherapy or in combination with colchicine.ilaris is also indicated for the treatment of:►still’s diseaseilaris is indicated for the treatment of active still’s disease including adult-onset still’s disease (aosd) and systemic juvenile idiopathic arthritis (sjia) in patients aged 2 years and older who have responded inadequately to previous therapy with non-steroidal anti-inflammatory drugs (nsaids) and systemic corticosteroids. ilaris can be given as monotherapy or in combination with methotrexate.►gouty arthritisilaris is indicated for the symptomatic treatment of adult patients with frequent gouty arthritis attacks (at least 3 attacks in the previous 12 months) in whom non-steroidal anti-inflammatory drugs (nsaids) and colchicine are contraindicated, are not tolerated, or do not provide an adequate response, and in whom repeated courses of corticosteroids are not appropriate

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

martin & pleasance pty ltd - trefriw wells mineral water -

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

martin & pleasance pty ltd - trefriw wells mineral water -

Սինգապուր - անգլերեն - HSA (Health Sciences Authority)

alcare pharmaceuticals pte ltd - cardiovascular - the steerable transseptal needle and its accessory piercing stylet are used in conjunction with a transseptal introducer to puncture the interatrial septum during a transseptal catheterization procedure to gain left heart access.

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

wellstat therapeutics corporation - uridine triacetate (unii: 2wp61f175m) (uridine - unii:whi7hq7h85) - uridine triacetate 951 mg in 1 g - vistogard® is indicated for the emergency treatment of adult and pediatric patients: - following a fluorouracil or capecitabine overdose regardless of the presence of symptoms, or - who exhibit early-onset, severe or life-threatening toxicity affecting the cardiac or central nervous system, and/or early-onset, unusually severe adverse reactions (e.g., gastrointestinal toxicity and/or neutropenia) within 96 hours following the end of fluorouracil or capecitabine administration. limitations of use - vistogard is not recommended for the non-emergent treatment of adverse reactions associated with fluorouracil or capecitabine because it may diminish the efficacy of these drugs. - the safety and efficacy of vistogard initiated more than 96 hours following the end of fluorouracil or capecitabine administration have not been established. none. risk summary limited case reports of uridine triacetate use during pregnancy are insufficient to inform a drug-associated risk of birth defects and miscarriage. when adminis

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

dr w y rambukwelle - 34627 - douche, - this small device (flow nozzle ) made from a special plastic, is 50mm long with a bend at about its middle and is 2mm in diameter. it should be used only once. it is for syringing ears to remove ear wax and should be used by registered medical practitioners and nurses only, after reading the detailed instructions supplied with each nozzle, including a diagram and when not to syringe an ear. the nozzle should be attached firmly to a clean 10 ml, single use plastic syringe with a 'luer lock'and clean water at body temperature should then be drawn into the syringe. the operator should then insert into the ear canal (which is 25mm deep) the furthermost 10 to 15 mm of the nozzle (from its tip) and douche the ear canal gently and repeatedly until all the wax has been removed. the nozzle ( and the syringe) should then be discarded. this method of ear syringing is much safer, simpler and cleaner than using the traditional metal ear syringe. this nozzle is being used in about 230 medical practices in new zealand over

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

wellspring pharmaceutical corporation - miconazole nitrate (unii: vw4h1cyw1k) (miconazole - unii:7nno0d7s5m) - miconazole nitrate 20 mg in 1 g - antifungal/antifúngico - proven clinically effective in the treatment of most athlete's foot, jock itch and ringworm / comprobado clínicamente para el tratamiento de la mayoría de los casos de pie de atleta, la sarna deportiva y la tiña - for effective relief of itching, scaling, burning and discomfort that can company these conditions / para el alivio efectivo de picazón, descamación, ardor y las molestias que pueden acompañar estas condiciones

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

wellspring pharmaceutical corporation - phenoxybenzamine hydrochloride (unii: x1ieg24ohl) (phenoxybenzamine - unii:0ttz664r7z) - phenoxybenzamine hydrochloride 10 mg

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

wellspring pharmaceutical corporation - triamterene (unii: ws821z52lq) (triamterene - unii:ws821z52lq) - triamterene 50 mg - dyrenium (triamterene) is indicated in the treatment of edema associated with congestive heart failure, cirrhosis of the liver and the nephrotic syndrome; steroid-induced edema, idiopathic edema and edema due to secondary hyperaldosteronism. dyrenium may be used alone or with other diuretics, either for its added diuretic effect or its potassium-sparing potential. it also promotes increased diuresis when patients prove resistant or only partially responsive to thiazides or other diuretics because of secondary hyperaldosteronism. usage in pregnancy . the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical consequences of pregnancy. diuretics are indicated in pregnancy (however, see preca